# Medial Epicondylitis: A Review of Clinical Presentation, Diagnosis, and Management in the United Kingdom

**Authors:** Abdullah Tahir, Nihal Chanian, Simrat Tiwana, Muhammad Arham Sahu, John Blackwell

PMC · DOI: 10.7759/cureus.102264 · Cureus · 2026-01-25

## TL;DR

This paper reviews how medial epicondylitis is diagnosed and treated in the UK, focusing on its causes, symptoms, and management strategies.

## Contribution

The paper provides a comprehensive overview of clinical practices for medial epicondylitis in the UK healthcare system.

## Key findings

- Diagnosis is primarily clinical, with imaging used selectively.
- Conservative therapy is the first-line treatment, with surgery reserved for resistant cases.
- Multidisciplinary care improves outcomes through coordinated strategies.

## Abstract

Medial epicondylitis is a chronic tendinopathic disorder involving the flexor-pronator origin of the medial elbow, characterised by pain and functional limitation related to repetitive loading and microtrauma. The condition exemplifies the broader spectrum of overuse injuries that result from cumulative strain exceeding the capacity for tendon repair. Diagnosis relies primarily on clinical evaluation, with imaging modalities used selectively to define the extent of pathology or to exclude alternative causes of medial elbow pain. Management follows a structured, stepwise approach, centred on conservative therapy, including rest, physiotherapy, and graduated strengthening programmes that are supported by adjunctive interventions when symptoms persist. Surgical management is considered only in cases of chronic, treatment-resistant disease. Growing recognition of this condition in both community and inpatient populations highlights its relevance to multidisciplinary care and underscores the value of coordinated management strategies that combine clinical assessment, rehabilitation, and targeted use of imaging to optimise outcomes.

## Full-text entities

- **Diseases:** oedema (MESH:C536897), avulsion (MESH:D000071562), arthritis (MESH:D001168), enthesopathy (MESH:D000070676), degenerative tendinopathy (MESH:D052256), Epicondylitis (MESH:D013716), erythema (MESH:D004890), angiofibroblastic hyperplasia (MESH:D006965), elbow (MESH:D000092464), Medial (MESH:D020423), deformity (MESH:D009140), reactive (MESH:D000275), myopathy (MESH:D009135), tenderness (MESH:D063806), neuropathic symptoms (MESH:D001750), calcification (MESH:D002114), weakness (MESH:D018908), radiculopathy (MESH:D011843), olecranon bursitis (MESH:D002062), ligamentous injuries (MESH:D000070598), bone marrow oedema (MESH:D004487), overuse injuries (MESH:D012090), inflammation (MESH:D007249), Elbow pain (MESH:D010146), shoulder weakness (MESH:D000070599), tendinopathic disorder (MESH:D009358), Medial Epicondylitis (MESH:D000070639), obesity (MESH:D009765), autoimmune arthropathies (MESH:D001327), ulnar nerve entrapment (MESH:D017769)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931734/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12931734/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12931734/full.md

---
Source: https://tomesphere.com/paper/PMC12931734